Vincent Lévêque

3.5k citations

41 papers · 1.8k · h-index 28

Impact in

Hepatology top 1%
- Hepatitis C virus research
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment

Papers in

Hepatology 24
- Hepatitis C virus research 24
Infectious Diseases 17
- HIV/AIDS drug development and treatment 16

Co-authors: Klaus Klumpp (20 shared papers)Isabel Nájera (16 shared papers)Han Ma (10 shared papers)Sophie Le Pogam (13 shared papers)Nick Cammack (10 shared papers)Sonal Rajyaguru (12 shared papers)Wen-Rong Jiang (6 shared papers)Harry S. Nick (5 shared papers)
Journals: Journal of Medicinal Chemistry (6 papers)Journal of Biological Chemistry (6 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Antiviral Research (3 papers)Virology (3 papers)
Partner nations: United States Switzerland Sweden

In The Last Decade

Vincent Lévêque

41 papers receiving 1.7k citations

Peers

Countries citing papers authored by Vincent Lévêque

Since Specialization

Citations

This map shows the geographic impact of Vincent Lévêque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lévêque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lévêque more than expected).

Fields of papers citing papers by Vincent Lévêque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lévêque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lévêque. The network helps show where Vincent Lévêque may publish in the future.

Co-authors

The 25 scholars most cited alongside Vincent Lévêque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Lévêque Line = papers co-authored together Vincent Lévêque links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture Journal of Biological Chemistry ·Klaus Klumpp, Vincent Lévêque, Sophie Le Pogam, Han Ma, Wen-Rong Jiang, Hyunsoon Kang, Caroline Granycome, Margaret Singer, Carl Laxton, Julie Q. Hang, Keshab Sarma, David B. Smith, Dieter Heindl, Chris Hobbs, John H. Merrett, Julian Symons, Nick Cammack, Joseph A. Martin, René Devos, Isabel Nájera	2005	167
2	Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus Journal of Virology ·Sophie Le Pogam, Hyunsoon Kang, Seth F. Harris, Vincent Lévêque, Anthony M. Giannetti, Samir Ali, Wen-Rong Jiang, Sonal Rajyaguru, Gisele Tavares, Connie Oshiro, Than Hendricks, Klaus Klumpp, Julian Symons, Michelle F. Browner, Nick Cammack, Isabel Nájera	2006	103
3	In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistance Virology ·Sophie Le Pogam, Wen-Rong Jiang, Vincent Lévêque, Sonal Rajyaguru, Han Ma, Hyunsoon Kang, Sharon Jiang, Margaret Singer, Samir Ali, Klaus Klumpp, Dave Smith, Julian Symons, Nick Cammack, Isabel Nájera	2006	101
4	Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479 Antimicrobial Agents and Chemotherapy ·Samir Ali, Vincent Lévêque, Sophie Le Pogam, Han Ma, Friederike Philipp, Nicole Inocencio, Mark Smith, André Alker, Hyunsoon Kang, Isabel Nájera, Klaus Klumpp, Julian Symons, Nick Cammack, Wen-Rong Jiang	2008	82
5	Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Inhibitor β-d-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and Identification of a Novel Active 5′-Triphosphate Species Journal of Biological Chemistry ·Han Ma, Wen-Rong Jiang, Nicole L. Robledo, Vincent Lévêque, Samir Ali, Teresa Lara‐Jaime, Mohammad R. Masjedizadeh, David B. Smith, Nick Cammack, Klaus Klumpp, Julian Symons	2007	79
6	Application of the Phosphoramidate ProTide Approach to 4‘-Azidouridine Confers Sub-micromolar Potency versus Hepatitis C Virus on an Inactive Nucleoside Journal of Medicinal Chemistry ·Plinio Perrone, G Luoni, Mary Rose Kelleher, Felice Daverio, Annette Angell, Sinéad Mulready, Costantino Congiatu, Sonal Rajyaguru, Joseph A. Martin, Vincent Lévêque, Sophie Le Pogam, Isabel Nájera, Klaus Klumpp, David B. Smith, Christopher McGuigan	2007	78
7	Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus Journal of Biological Chemistry ·Julie Q. Hang, Yanli Yang, Seth F. Harris, Vincent Lévêque, Hannah J. Whittington, Sonal Rajyaguru, Gloria Ao-Ieong, Matthew F. McCown, April Wong, Anthony M. Giannetti, Sophie Le Pogam, Francisco X. Talamás, Nick Cammack, Isabel Nájera, Klaus Klumpp	2009	71
8	The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine Journal of Medicinal Chemistry ·David B. Smith, Genadiy Kalayanov, Christian Sund, Anna Winqvist, T. V. Maltseva, Vincent Lévêque, Sonal Rajyaguru, Sophie Le Pogam, Isabel Nájera, Kurt Benkestock, Xiaoxiong Zhou, Ann C. Kaiser, Hans Maag, Nick Cammack, Joseph A. Martin, Steven Swallow, Nils Gunnar Johansson, Klaus Klumpp, Mark A. Smith	2009	70
9	OA20.01 Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients Journal of Thoracic Oncology ·Marcin Kowanetz, Wei Zou, David S. Shames, Craig Cummings, Naiyer A. Rizvi, Alexander I. Spira, Garrett M. Frampton, Vincent Lévêque, Susan Flynn, Simonetta Mocci, Geetha Shankar, Roel Funke, Marcus Ballinger, Daniel Waterkamp, Daniel Chen, Alan Sandler, Garret M. Hampton, Lukas C. Amler, Priti S. Hegde, Matthew D. Hellmann	2017	63
10	The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein Virology ·Choong-Ho Lee, Han Ma, Julie Q. Hang, Vincent Lévêque, Ella H. Sklan, Menashe Elazar, Klaus Klumpp, Jeffrey S. Glenn	2011	62
11	First Example of Phosphoramidate Approach Applied to a 4‘-Substituted Purine Nucleoside (4‘-Azidoadenosine): Conversion of an Inactive Nucleoside to a Submicromolar Compound versus Hepatitis C Virus Journal of Medicinal Chemistry ·Plinio Perrone, Felice Daverio, Rocco Valente, Sonal Rajyaguru, Joseph A. Martin, Vincent Lévêque, Sophie Le Pogam, Isabel Nájera, Klaus Klumpp, David B. Smith, Christopher McGuigan	2007	57
12	Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate PLoS ONE ·Bindumadhav M. Marathe, Vincent Lévêque, Klaus Klumpp, Robert G. Webster, Elena A. Govorkova	2013	54
13	Multiple Replacements of Glutamine 143 in Human Manganese Superoxide Dismutase: Effects on Structure, Stability, and Catalysis Biochemistry ·Vincent Lévêque, M. Elizabeth Stroupe, James R. Lepock, Diane E. Cabelli, John A. Tainer, Harry S. Nick, David N. Silverman	2000	53
14	Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors Virology ·Han Ma, Vincent Lévêque, Anniek De Witte, Weixing Li, Than Hendricks, Saundra M. Clausen, Nick Cammack, Klaus Klumpp	2004	52
15	Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors Bioorganic & Medicinal Chemistry Letters ·Stephen Antonysamy, Brandon E. Aubol, Jeff Blaney, Michelle F. Browner, Anthony M. Giannetti, Seth F. Harris, Normand Hébert, J. Hendle, Stephanie Hopkins, Elizabeth A. Jefferson, Charles R. Kissinger, Vincent Lévêque, David Marciano, Ethel McGee, Isabel Nájera, Brian E. Nolan, Masaki Tomimoto, Eduardo Torres, Tobi A. Wright	2008	52
16	Interrupting the Hydrogen Bond Network at the Active Site of Human Manganese Superoxide Dismutase Journal of Biological Chemistry ·Cecilia A. Ramilo, Vincent Lévêque, Yue Guan, James R. Lepock, John A. Tainer, Harry S. Nick, David N. Silverman	1999	51
17	Redox Properties of Human Manganese Superoxide Dismutase and Active-Site Mutants Biochemistry ·Vincent Lévêque, Carrie K. Vance, Harry S. Nick, David N. Silverman	2001	50
18	3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase Bioorganic & Medicinal Chemistry Letters ·R. Hendricks, Stacey R. Spencer, James F. Blake, Jay B. Fell, John P. Fischer, Peter J. Stengel, Vincent Lévêque, Sophie LePogam, Sonal Rajyaguru, Isabel Nájera, John A. Josey, Steven Swallow	2008	47
19	Assembly, Purification, and Pre-steady-state Kinetic Analysis of Active RNA-dependent RNA Polymerase Elongation Complex Journal of Biological Chemistry ·Zhinan Jin, Vincent Lévêque, Han Ma, Kenneth A. Johnson, Klaus Klumpp	2012	43
20	Identification of a C-Terminal Regulatory Motif in Hepatitis C Virus RNA-Dependent RNA Polymerase: Structural and Biochemical Analysis Journal of Virology ·Vincent Lévêque, Robert B. Johnson, Stephen H. Parsons, Jianxin Ren, Congping Xie, Faming Zhang, Q. May Wang	2003	38

About Vincent Lévêque

Vincent Lévêque is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (24 papers), HIV/AIDS drug development and treatment (16 papers), Hepatitis B Virus Studies (13 papers), Biochemical and Molecular Research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers) and Metal-Catalyzed Oxygenation Mechanisms (4 papers). The work is most often cited by research in Hepatology (788 citations), Infectious Diseases (604 citations), Virology (123 citations), Epidemiology (568 citations) and Inorganic Chemistry (151 citations). Vincent Lévêque has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include Klaus Klumpp, Isabel Nájera, Han Ma, Sophie Le Pogam, Nick Cammack, Sonal Rajyaguru, Wen-Rong Jiang, Harry S. Nick, David N. Silverman and Julian Symons. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Antiviral Research and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Vincent Lévêque

Impact in

Papers in i

In The Last Decade

Vincent Lévêque

Peers

Countries citing papers authored by Vincent Lévêque

Fields of papers citing papers by Vincent Lévêque

All Works

About Vincent Lévêque

Explore authors with similar magnitude of impact

Papers in